165965 Changing role of the consumer in long-term care

Tuesday, November 6, 2007: 12:50 PM

Enid Kassner , Strategic Policy Advisor, AARP Public Policy Institute, Washington, DC
For many years, people who needed long-term care were served in institutions. Not until the early 1980s did Medicaid, the nation's primary source of payment for long-term care, begin to authorize the delivery of home and community-based services (HCBS): a change that came in the wake of the disability rights movement. While there still is much progress to be made, the growth in the percentage of Medicaid funding going to HCBS, rather than institutions, has doubled over the past 10 years – albeit with significant variation among the states.

However, even these HCBS traditionally were delivered in a “case management” model, in which beneficiaries had restricted choices as to the provider, type, and timing of services. In response to advocacy by consumers and innovative pilot programs, the use of “consumer directed” HCBS has grown and, today, nearly all states have at least some such options for people who need long-term care.

This presentation will describe not only these changes in the direction of public policy, but also the American Association for Retired Persons (AARP) evolution in its advocacy for long-term care.

Learning Objectives:
To examine the historical context for the delivery of long-term care and the advent of home and community-based services (HCBS). To learn how the shift from “case management” to “consumer directed” home and community based services has occurred through public policy advocacy. To identify innovative programs that utilize a “consumer directed” model in HCBS. To discuss the evolutionary role of AARP in advocating for public policies that address long-term care.

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.